DK1185267T3 - Dermale bedövelsesmidler - Google Patents

Dermale bedövelsesmidler

Info

Publication number
DK1185267T3
DK1185267T3 DK00941227T DK00941227T DK1185267T3 DK 1185267 T3 DK1185267 T3 DK 1185267T3 DK 00941227 T DK00941227 T DK 00941227T DK 00941227 T DK00941227 T DK 00941227T DK 1185267 T3 DK1185267 T3 DK 1185267T3
Authority
DK
Denmark
Prior art keywords
compounds
anesthetics
dermal
aminoindane
dermal anesthetics
Prior art date
Application number
DK00941227T
Other languages
Danish (da)
English (en)
Inventor
A K Gunnar Aberg
Jan L Chen
George L Wright
Original Assignee
Bridge Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bridge Pharma Inc filed Critical Bridge Pharma Inc
Application granted granted Critical
Publication of DK1185267T3 publication Critical patent/DK1185267T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00941227T 1999-06-10 2000-06-06 Dermale bedövelsesmidler DK1185267T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13835399P 1999-06-10 1999-06-10
US17926700P 2000-01-31 2000-01-31

Publications (1)

Publication Number Publication Date
DK1185267T3 true DK1185267T3 (da) 2006-12-11

Family

ID=26836123

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00941227T DK1185267T3 (da) 1999-06-10 2000-06-06 Dermale bedövelsesmidler

Country Status (18)

Country Link
US (1) US6413987B1 (OSRAM)
EP (1) EP1185267B1 (OSRAM)
JP (1) JP2003501469A (OSRAM)
CN (1) CN1355700A (OSRAM)
AT (1) ATE335482T1 (OSRAM)
AU (1) AU777517B2 (OSRAM)
BR (1) BR0011028A (OSRAM)
CA (1) CA2376819C (OSRAM)
CY (1) CY1105721T1 (OSRAM)
DE (1) DE60029954T2 (OSRAM)
DK (1) DK1185267T3 (OSRAM)
ES (1) ES2267546T3 (OSRAM)
IL (2) IL146190A0 (OSRAM)
MX (1) MXPA01012632A (OSRAM)
NO (1) NO323856B1 (OSRAM)
NZ (1) NZ515143A (OSRAM)
PT (1) PT1185267E (OSRAM)
WO (1) WO2000076510A1 (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1321139T1 (sl) * 2001-12-21 2007-02-28 Chiesi Farma Spa 2-indanilamino-derivati za zdravljenje kronicne, akutne ali vnetne bolecine
PL376890A1 (pl) * 2002-11-26 2006-01-09 Maruishi Pharmaceutical Co., Ltd. Pochodne izoindoliny
WO2006037047A2 (en) * 2004-09-27 2006-04-06 Bridge Pharma, Inc. The r-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
US7718674B2 (en) 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
US20090137628A1 (en) * 2005-09-23 2009-05-28 Bridge Pharma, Inc. Formulations of Indanylamines and the Use Thereof as Local Anesthetics and as Medication for Chronic Pain
US20110218218A1 (en) * 2005-09-23 2011-09-08 Bridge Pharma, Inc. Formulations Of Indanylamines And The Use Thereof As Local Anesthetics And As Medication For Chronic Pain
CA2655809C (en) 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds
DK2244737T3 (da) * 2008-01-22 2019-07-08 Univ Texas Flygtige anæstetiske sammensætninger omfattende ekstraktionsopløsningsmidler til regional anæstesi og/eller smertelindring
BR112013020874A2 (pt) * 2011-02-18 2019-05-21 Endo Pharmaceuticals Inc. composto, regime, método para a preparação do referido composto, e, uso de um composto
US8809372B2 (en) 2011-09-30 2014-08-19 Asana Biosciences, Llc Pyridine derivatives
US8685418B2 (en) 2011-10-24 2014-04-01 Endo Pharmaceuticals Inc. Cyclohexylamines
US9044482B2 (en) 2012-08-15 2015-06-02 Asana Biosciences, Llc Use of aminoindane compounds in treating overactive bladder and interstitial cystitis
EA201891225A1 (ru) 2015-11-23 2018-11-30 Грейс Терапьютикс Ллк Пленкообразующий спрей для местного применения
JP7656266B2 (ja) 2018-12-19 2025-04-03 グレイス セラピューティクス、インコーポレイテッド 鼻腔内リドカインの治療用組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE760018A (fr) * 1969-12-19 1971-06-08 Christiaens Sa A Nouveau derives du 2-amino-indane, leur preparation et leur utilisation
US3923813A (en) 1969-12-19 1975-12-02 Christiaens Sa A Derivatives of 2-aminoindanes
AR206505A1 (es) * 1972-09-18 1976-07-30 Christiaens Sa A Procedimiento para obtener nuevos derivados de n-fenil-n-aminoalquil-2-aminoindano
ZA738419B (en) 1972-11-06 1974-09-25 Christiaens Sa A New derivatives of 2-aminoindane,the preparation and use thereof
GB1462036A (en) * 1973-02-05 1977-01-19 Manuf Prod Pharma Aminoindane derivatives
GB1468347A (en) * 1973-03-02 1977-03-23 Christiaens Sa A Aminoindanes

Also Published As

Publication number Publication date
MXPA01012632A (es) 2004-03-19
US6413987B1 (en) 2002-07-02
CN1355700A (zh) 2002-06-26
CA2376819A1 (en) 2000-12-21
NO20016037D0 (no) 2001-12-10
CA2376819C (en) 2008-09-02
EP1185267A4 (en) 2003-09-03
WO2000076510A9 (en) 2002-07-04
CY1105721T1 (el) 2010-12-22
JP2003501469A (ja) 2003-01-14
WO2000076510A1 (en) 2000-12-21
DE60029954T2 (de) 2007-03-08
DE60029954D1 (de) 2006-09-21
EP1185267A1 (en) 2002-03-13
BR0011028A (pt) 2002-02-19
EP1185267B1 (en) 2006-08-09
IL146190A0 (en) 2002-07-25
AU5596300A (en) 2001-01-02
NZ515143A (en) 2004-05-28
ES2267546T3 (es) 2007-03-16
NO323856B1 (no) 2007-07-16
AU777517B2 (en) 2004-10-21
IL146190A (en) 2008-11-03
PT1185267E (pt) 2006-12-29
ATE335482T1 (de) 2006-09-15
NO20016037L (no) 2002-02-11

Similar Documents

Publication Publication Date Title
TR200102800T2 (tr) Yeni bileşikler.
ATE335482T1 (de) Dermale anästhetika
DE60012188D1 (de) Fungizide
BR9806296B1 (pt) compostos de ácido sulfìnico, mistura, composição e uso dos mesmos.
MX9702865A (es) Agentes estrogenicos.
ATE273690T1 (de) Zusammensetzung zur hautdesinfizierung
BR9708639A (pt) Composição estabilizadora
ATE233484T1 (de) Desinfizierende zusammensetzung
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
BG104232A (bg) Заместени 1,2,3,4,5,6-хексахидро-2,6-метано-3-бензазоцин- 10-оли, метод за тяхното получаване и приложението им като лекарствени средства
DK1204659T3 (da) Serotonerge benzofuraner
DE60041001D1 (de) Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
ID27440A (id) Proses untuk menyiapkan penengah-penengah
DE59803066D1 (de) Substituierte benzyloxyimino-verbindungen
DK1144423T3 (da) Bis-terpyridin-platin(II)-komplekser
MY130184A (en) Dermal anesthetic agents
EP1658847A3 (en) Indane derivatives as dermal anesthetic agents
ATE385792T1 (de) Verwendung von derivaten von c2-substituierten indan-1-ol-systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas
CA2425164A1 (en) (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists
DE60222236D1 (de) Zubereitungen enthaltend cyclohexamantan
AU2001287673A1 (en) Novel trioxepan compounds
MXPA03003466A (es) Derivados de piranosido.
DE59911958D1 (de) Fluorierte 3,4-dihydrochinolin-derivative als nos-inhibitoren